Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Rafael Holdings Inc RFL

Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and medical devices in the United States and Israel. It operates in three segments, Healthcare, Infusion Technology, and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer... see more

Current News (NYSE:RFL)

Rafael Holdings Reports First Quarter Fiscal 2026 Financial Results

GlobeNewswire December 11, 2025

Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results

GlobeNewswire October 29, 2025

Rafael Holdings Mourns the Passing of Lead Independent Director, Stephen Greenberg, and Announces the Appointment of Alan Grayson to its Board of Directors

GlobeNewswire October 28, 2025

Rafael Holdings Announces Presentation of Preliminary Data from Ongoing Phase 3 TransportNPC(TM) Open-Label, Single-Arm Sub-Study in Patients Less Than 3 Years Old

GlobeNewswire September 16, 2025

Rafael Holdings Announces Abstracts Accepted for Oral and Poster Presentations at the 15th International Congress of Inborn Errors of Metabolism (ICIEM)

GlobeNewswire August 27, 2025

Rafael Holdings Announces Continuation of its Phase 3 Study for the Treatment of Niemann-Pick Disease Type C1 (NPC1) Following Independent Data Monitoring Committee (DMC) Review of Prespecified 48-Week Interim Data

GlobeNewswire June 18, 2025

Rafael Holdings Reports Third Quarter Fiscal 2025 Financial Results

GlobeNewswire June 11, 2025

Rafael Holdings, Inc. Announces Final Results and Closing of Rights Offering

GlobeNewswire June 4, 2025

Rafael Holdings, Inc. Provides Update to the Description of Subscription Rights Related to its Public Warrants in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo(TM)

GlobeNewswire May 20, 2025

Opinion & Analysis (NYSE:RFL)

No current opinion is available.

Bullboard Posts (NYSE:RFL)

Using technical analysis for this stock.

It is signalling a big uptrend for shareholders this morning
coolfooldumbguy - June 10, 2025

Rafael Holdings (RFL): Navigating the Evolving Healthcare La

https://beyondspx.com/article/rafael-holdings-rfl-navigating-the-evolving-healthcare-landscape
MikeTester - January 22, 2025

5 REASONS WHY RAFAEL HOLDINGS IS A RISKY INVESTMENT!

$RFL   Rafael Holdings Inc, whose subsidiaries include Rafael Pharmaceuticals, Inc. and LipoMedix Pharmaceuticals Ltd, has...
AviseAnalytics - November 29, 2021

Podcasts